Press Releases
-
DaVita Inc. Announces Exchange Offer for its 9 1/4% Senior Subordinated Notes Due 2011
DaVita Inc. announced today its offer to exchange $225 million of its 9 1/4% Senior Subordinated Notes due 2011, which have been registered under the Securities Act of 1933, for its outstanding 9...
-
Davita Announces Second Quarter Earnings Release
We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on...
-
Nancy-Ann DeParle and William L. Roper Join DaVita Board of Directors
DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors...
-
DaVita says price of Amgen’s Epogen raised 3.9 pct
Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) - DaVita Inc. (NYSE:DVA), an...
-
Amgen Raises EPOGEN Pricing
DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing...